Sustainable Innovation

A core commitment at Biovance Capital

Environmental Stewardship
We invest in companies committed to reducing their environmental impact. This includes green technologies, efficient processes, and sustainable materials in pharmaceutical production. We believe minimizing environmental footprints is essential for long-term industry success.

Social Responsability
Biovance Capital champions social responsibility within its portfolio companies. We support initiatives that improve access to therapies, ensure safety, and promote diversity in the industry. Advancing healthcare solutions also means promoting equity for everyone.

Governance Excellence
Biovance Capital champions social responsibility within its portfolio companies. We support initiatives that improve access to therapies, ensure safety, and promote diversity in the industry. Advancing healthcare solutions also means promoting equity for everyone.
Our sustainability strategy
At Biovance Capital, sustainability is at the heart of our investment philosophy. We recognize that true innovation in the biopharma and biotech sectors must go hand in hand with responsible, sustainable practices.

Strategic Support
Strategic Support

Resource Sharing
Resource Sharing

Advocacy and Thought Leadership
Advocacy and Thought Leadership
Our commitment is to invest in companies that not only push the boundaries of science but also prioritize the well-being of our planet and society. We believe that the future of healthcare innovation is sustainable. Our approach is designed to identify and support companies that are leading the charge in sustainable practices, from reducing their environmental footprint to fostering inclusive, ethical growth.
Our aim is clear.

Green Biotechnologies
Supporting the development of sustainable lab technologies and energy-efficient manufacturing processes to minimize waste and reduce carbon footprints.

Access to Medicine
Investing in solutions that make life-saving therapies more accessible to underserved populations, promoting health equity globally.

Circular Economy Practice
Backing companies that are innovating in waste management and resource reuse, creating a more sustainable supply chain in biopharma.
Driving impact through sustainable innovation.
Biovance Capital is committed to driving impact through sustainable innovation. We invest in companies that are not only on the cutting edge of biopharma and biotech but are also setting new standards for sustainability in the industry. From pioneering waste reduction strategies to developing environmentally-friendly production methods, our portfolio companies are at the forefront of sustainable healthcare innovation.


Sourcing
Sustainability risks, including the sector in which companies operate, are considered during the research process for new investment opportunities.

Investment Analysis
After the initial analysis based on external elements, additional information is collected, including data provided by the target entity, to conduct a more detailed analysis.

Due Diligence
During the due diligence process, sustainability risks are taken into account, and whenever identified, mitigation measures are proposed.

Investment Decision
During the decision-making phase, all risks, including sustainability risks, are considered, and the operational and financial impacts are estimated.

Portfolio Monitoring
Throughout the investment period, regular monitoring of the portfolio includes sustainability indicators and appropriate mitigation measures when required.